Company news: Zelira Therapeutics; Epsilon Healthcare; Creso Pharma by Martin Lane and Steve Jones May 23, 2023May 23, 2023 ASX-listed Zelira Therapeutics has raised another US$3.25 million (A$4.89m) towards the cost of its US clinical […]
Epsilon secures A$1.65m in capital raise with backing from former CEO by Steve Jones September 2, 2022September 2, 2022
Epsilon future uncertain as half-year losses climb by 94% by Martin Lane September 1, 2022September 1, 2022
Company news: Rua Bioscience; Emyria; InhaleRx; Cannasouth; Roots: Creso Pharma; Epsilon by cannabiz team December 2, 2021December 2, 2021
Epsilon and Cannim enter into manufacturing agreement by Hannah Adler October 21, 2021October 21, 2021
Epsilon Healthcare and The Valens Company enter into exclusive partnership by Hannah Adler September 9, 2021September 10, 2021
Company news: Elixinol Global; Bod Australia; MGC Pharma; Cronos Australia; Epsilon Healthcare by Martin Lane April 23, 2021April 29, 2021
